Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong
· Delayed Price · Currency is HKD | Market Cap | 173.76B |
| Revenue (ttm) | 16.72B |
| Net Income (ttm) | 6.18B |
| Shares Out | 6.06B |
| EPS (ttm) | 1.03 |
| PE Ratio | 27.72 |
| Forward PE | 25.24 |
| Dividend | 0.43 (1.51%) |
| Ex-Dividend Date | Jul 3, 2026 |
| Volume | 14,381,418 |
| Average Volume | 13,051,464 |
| Open | 28.98 |
| Previous Close | 28.76 |
| Day's Range | 28.14 - 29.32 |
| 52-Week Range | 28.06 - 44.22 |
| Beta | 0.52 |
| RSI | 28.24 |
| Earnings Date | Aug 18, 2026 |
About HKG:3692
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and ... [Read more]
Financial Performance
In 2025, HKG:3692's revenue was 15.03 billion, an increase of 22.57% compared to the previous year's 12.26 billion. Earnings were 5.56 billion, an increase of 27.07%.
Financial numbers in CNY Financial StatementsAnalyst Forecast
According to 22 analysts, the average rating for 3692 stock is "Strong Buy." The 12-month stock price target is $46.87, which is an increase of 63.54% from the latest price.
News
China's Hansoh Pharmaceutical Group beats net profit expectations in 2025
China's Hansoh Pharmaceutical Group , a Roche partner, reported a 27% rise in annual profit on Sunday, beating market expectations and boosted by income from innovative medicines and business develo...
Hansoh Pharmaceutical Group Company Earnings release: H2 2025
Hansoh Pharmaceutical Group Company released its H2 2025 earnings on March 28, 2026, summarizing the period's financial results.
Hansoh Pharmaceutical Group Company Annual report: H2 2025
Hansoh Pharmaceutical Group Company has published its H2 2025 annual report on March 28, 2026.
Hansoh Pharmaceutical Group Company Quarterly report: H1 2025
Hansoh Pharmaceutical Group Company has published its H1 2025 quarterly earnings report on August 17, 2025.
Hansoh Pharmaceutical Group Company Earnings release: H1 2025
Hansoh Pharmaceutical Group Company released its H1 2025 earnings on August 17, 2025, summarizing the period's financial results.